Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone

被引:82
作者
Jonas, JB
Hayler, JK
Söfker, A
Panda-Jonas, S
机构
[1] Univ Heidelberg, Dept Ophthalmol, Heidelberg, Germany
[2] Univ Heidelberg, Hosp Eye, Fac Clin Med Mannheim, Heidelberg, Germany
[3] Univ Erlangen Nurnberg, Dept Ophthalmol, D-8520 Erlangen, Germany
[4] Univ Erlangen Nurnberg, Hosp Eye, D-8520 Erlangen, Germany
关键词
intravitreal crystalline cortisone; iris neovascularization; secondary angle-closure glaucoma; triamcinolone acetonide;
D O I
10.1097/00061198-200108000-00007
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report the clinical outcome of patients who received an intravitreal injection of crystalline triamcinolone acetonide as treatment of neovascular glaucoma. Patients and Methods: The study included 14 eyes of 14 patients with secondary neovascular glaucoma attributable to proliferative diabetic retinopathy (n = 9) or ischemic central retinal vein occlusion (n = 5). All patients received an intravitreal injection of 20 mg of crystalline triamcinolone acetonide as the only procedure (n = 4) or in combination with additional procedures, such as goniosynechiolysis (n = 1), phacoemulsification and intraocular lens implantation (n = 2), or transscleral peripheral retinal cryocoagulation (n = 7). Mean follow-up time was 3.10 +/- 2.40 months (median. 3.5 months; range, 0.50-5.7 months). A goniosynechiolysis was carried out in those patients in whom the anterior chamber was circumferentially closed. Results: After surgery, including the first days after surgery, the patients were nearly pain-free. Intraocular pressure was significantly (P < 0.01) reduced from 33.4 +/- 14.5 mm Hg before surgery to 20.7 +/- 8.2 mm Hg at the end of the follow-up period. Postoperative visual acuity (mean, 0.09 +/- 0.07; median, 0.10; range, finger counting to 0.25) was slightly but not significantly (P < 0.31) better than the preoperative values. Degree of rubeosis iridis decreased significantly (P = 0.02) from 2.6 +/- 1.3 relative units to 1.3 +/- 1.2 relative units. When considering only the four patients for whom the intraocular cortisone injection was the only procedure performed, mean intraocular pressure decreased from 26.5 +/- 12.1 mm Hg to 21.75 +/- 11.3 mm Hg. Conclusions: Intravitreal injection of crystalline cortisone with most of the vehicle removed may be a potentially useful additional tool in the treatment of neovascular glaucoma.
引用
收藏
页码:284 / 287
页数:4
相关论文
共 19 条
[11]  
Machemer R, 1979, Trans Am Ophthalmol Soc, V77, P171
[12]  
Machemer R, 1996, RETINA-J RET VIT DIS, V16, P166, DOI 10.1097/00006982-199616020-00017
[13]  
MACHEMER R, 1988, INVEST OPHTH VIS SCI, V29, P1771
[14]   THE LACK OF TOXICITY OF INTRAVITREALLY ADMINISTERED TRIAMCINOLONE ACETONIDE [J].
MCCUEN, BW ;
BESSLER, M ;
TANO, Y ;
CHANDLER, D ;
MACHEMER, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 91 (06) :785-788
[15]   Evaluation of an integrated management and compliance program for Tomicus piniperda (Coleoptera: Scolytidae) in pine christmas tree fields [J].
McCullough, DG ;
Sadof, CS .
JOURNAL OF ECONOMIC ENTOMOLOGY, 1998, 91 (04) :785-795
[16]   THE CLEARANCE OF INTRAVITREAL TRIAMCINOLONE ACETONIDE [J].
SCHINDLER, RH ;
CHANDLER, D ;
THRESHER, R ;
MACHEMER, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 93 (04) :415-417
[17]   INHIBITION OF INTRA-OCULAR PROLIFERATIONS WITH INTRAVITREAL CORTICOSTERIODS [J].
TANO, Y ;
SUGITA, G ;
ABRAMS, G ;
MACHEMER, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1980, 89 (01) :131-136
[18]   GLUCOCORTICOSTEROID INHIBITION OF INTRAOCULAR PROLIFERATION AFTER INJURY [J].
TANO, Y ;
CHANDLER, DB ;
MCCUEN, BW ;
MACHEMER, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 91 (02) :184-189
[19]   TREATMENT OF INTRAOCULAR PROLIFERATION WITH INTRAVITREAL INJECTION OF TRIAMCINOLONE ACETONIDE [J].
TANO, Y ;
CHANDLER, D ;
MACHEMER, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1980, 90 (06) :810-816